Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure-a claims data analysis.

Authors

Lisa-Marie Müller, Jonas Krampe, Julius L Katzmann, Ulrich Laufs, Alexander Kogel

Published in

Clinical research in cardiology : official journal of the German Cardiac Society. Jul 07, 2026. Epub Jul 07, 2026.

Abstract

This study was aimed at analysing the association between socioeconomic factors and SGLT2 inhibitor (SGLT2i) initiation in patients with heart failure.
In this retrospective analysis, German health insurance claims data from 2022 to 2023 were used, covering more than 2.8 million individuals. Heart failure was defined using ICD-10-GM codes. Area-based socioeconomic data were obtained from the INKAR database. Associations were assessed using a multilevel logistic regression analysis.
In 2023, 90,841 individuals were diagnosed with heart failure. After excluding patients with prior SGLT2i use in 2022 and those with missing data, 68,426 SGLT2i-naive individuals were included in the analysis. A higher likelihood of SGLT2i initiation was associated with newly coded heart failure (adjusted odds ratio (aOR): 2.42, 95% CI 2.29-2.56) and new enrolment in a disease management program for coronary artery disease (aOR: 1.89, 95% CI 1.68-2.12). Being a pensioner (aOR: 0.86, 95% CI 0.78-0.93), having family insurance (aOR: 0.79, 95% CI 0.66-0.95), moving (aOR: 0.80, 95% CI 0.67-0.95), being female (aOR: 0.83, 95% CI 0.78-0.87), and older age (aOR: 0.37, 95% CI 0.18-0.76) were negatively associated. At the municipal level, residing in a higher-income tax municipality (aOR: 1.70, 95% CI 1.37-2.09) was positively related to SGLT2i initiation. These associations were adjusted for other socioeconomic factors, comorbidities, and heart failure medications.
Women and individuals living in socioeconomically disadvantaged municipalities were less likely to receive SGLT2i initiation for heart failure.

PMID:
42412223
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.